Corporate Transformation

Novartis CEO explains the radical rethink that transformed a 250-year-old pharma giant

Novartis CEO Vasant Narasimhan describes the strategic decision to transform the company into a pure-play biopharmaceuticals business. He explains how they exited the consumer health business through a GSK joint venture and focused on specific therapeutic areas they believed would have the greatest impact.